Read Announcement View Product Photos Summary Company Announcement Date: FDA Publish Date: Product Type: Drugs Reason for Announcement: Recall Reason DescriptionN-Nitroso Varenicline content above ADI level Company Name: Pfizer Brand Name: Brand Name(s)CHANTIX Product Description: Product DescriptionSmoking cessation treatment Company Announcement Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level
Conclusions Cigarette additives and ingredients with chemosensory effects that promote addiction by acting synergistically with nicotine, increasing product appeal, easing smoking initiation, discouraging cessation or promoting relapse should be regulated by the US Food and Drug Administration
Direct and indirect associations between social anxiety and nicotine dependence and cessation problems: Multiple mediator analyses
Cigars factored heavily into the series, both on and off the set
Now I just feel absolutely disappointed." His friend's suicide, Steadman admits, has started to focus his thoughts on his own morality
and by that point he'd committed
